Skip to content
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
2018
09 • 25 • 2018
NervGen Pharma Appoints Dr. Michael Abrams to Board of Directors
08 • 10 • 2018
NervGen Pharma Announces Granting of US Patent for Breakthrough Nerve Regeneration Technology
07 • 17 • 2018
NervGen Pharma Licenses Breakthrough Nerve Regeneration Technology from Case Western Reserve University
06 • 21 • 2018
NervGen Pharma Appoints Dr. Ernest Wong as President & CEO
No posts found